The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

Nelson Leung(WinnMed), Samih H. Nasr(Mayo Clinic), Paul Cockwell(University Hospitals Birmingham NHS Foundation Trust), Brendan M. Weiss(Heidelberg University), Efstathios Kastritis(National and Kapodistrian University of Athens), Aristeidis Chaidos(British Society for Haematology), Helen J. Lachmann(Royal Free London NHS Foundation Trust), Dragan Jevremović(Mayo Clinic in Arizona), Robert A. Kyle(Mayo Clinic), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Vecihi Batuman(Tulane University), Heinz Ludwig(Wilhelminen Hospital), Simon Gibbs(Amyloidosis Foundation), Christopher P. Larsen(Arkana Laboratories), Paul W. Sanders(Deakin University), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), S. Vincent Rajkumar(WinnMed), Vishal Kukreti(University Health Network), Ashutosh Wechalekar(University College Hospital), Sanjeev Sethi(Mayo Clinic), Peter M. Voorhees(Levine Cancer Institute), Fernando C. Fervenza(Mayo Clinic), Virginie Royal(Hôpital Maisonneuve-Rosemont), Peter Mollee(The University of Queensland), Giampaolo Merlini(University of Pavia), Frank Bridoux(Université de Poitiers), Maria M. Picken(Loyola University Medical Center), Guillermo A. Herrera(Louisiana State University Health Sciences Center Shreveport), Vivette D. D’Agati(Columbia University), Jean-Paul Fermand(Hôpital Saint-Louis), Angela Dispenzieri(Mayo Clinic), Glen S. Markowitz(Columbia University Irving Medical Center), Christopher P. Venner(BC Cancer Agency)

Nature Reviews Nephrology

December 3, 2018

Cited by 544

Related Papers

|Journal of Clinical Oncology|2005|2.9k

|New England Journal of Medicine|2018|2.8k

|Leukemia|2006|2.6k

|Kidney International|2021|2.5k

|Journal of Clinical Oncology|2015|2.2k